Savola, P.
Kelkka, T. http://orcid.org/0000-0003-1085-6382
Rajala, H. L.
Kuuliala, A.
Kuuliala, K.
Eldfors, S.
Ellonen, P.
Lagström, S.
Lepistö, M.
Hannunen, T.
Andersson, E. I.
Khajuria, R. K.
Jaatinen, T.
Koivuniemi, R.
Repo, H.
Saarela, J.
Porkka, K.
Leirisalo-Repo, M.
Mustjoki, S.
Article History
Received: 17 June 2016
Accepted: 4 May 2017
First Online: 21 June 2017
Competing interests
: S.M. and K.P. have received honoraria and research funding from Novartis, Bristol-Myers Squibb and Pfizer. S.M. has received research funding from Ariad. J.S. has received lecture fees from Roche. The remaining authors declare no competing financial interests.